Thumbnail Image
Publication

Pharmacogenomics is the future of prescribing inpsychiatry

Jameson, A.
; ; 
Bristow, Greg C.
; 
Cardno, A.
; 
Dalton, C.
; 
Sagoo, G.
; 
Sohal, J.
; 
Publication Date
10/08/2022
End of Embargo
Supervisor
Keywords
Pharmacogenomics, Psychiatry, Prescribing, Therapeutic response, Adverse drug reactions
Rights
(c) 2022 The Pharmaceutical Journal. Full-text reproduced in accordance with the publisher's self-archiving policy.
cb
Peer-Reviewed
Yes
Open Access status
openAccess
Accepted for publication
13/07/2023
Institution
Department
Awarded
Embargo end date
Collections
Life Sciences Publications
Show all metadata
Files
Thumbnail Image
jameson_et_al_2022.pdf
Adobe PDF, 157.73 KB
Thumbnail Image
Keep suppressed - no permission
Adobe PDF, 2.1 MB
Additional title
Abstract
Patients' pharmacogenetic data could be used to improve adherence to antipsychotic medication by increasing the likelihood of therapeutic response and reducing the prevalence of adverse drug reactions.
URI
http://hdl.handle.net/10454/19587
Version
Accepted manuscript
Citation
Jameson A, Fylan B, Bristow GC et al (2022) Pharmacogenomics is the future of prescribing in psychiatry. Pharmaceutical Journal. 209: 7964.
Link to publisher’s version
Link to published version
Link to Version of Record
https://doi.org/10.1211/PJ.2022.1.152215
Type
Article
Qualification name
Notes